Latest Methicillin-resistant Staphylococcus aureus Stories
VIENNA and PHILADELPHIA, October 8, 2014 /PRNewswire/ -- Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics
LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that
Topical report “Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014” worked out by Global Markets Direct is now available at MarketPublishers.com.
- Lead Product DALVANCE(TM) a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - DUBLIN, Ireland and CHICAGO, Oct.
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
ROUND ROCK, Texas, Oct.
CHICAGO, Oct. 1, 2014 /PRNewswire-USNewswire/ -- 'The MRSA Epidemic - A Call to Action' is this year's global theme.
PDI Sani-Hands® Instant Hand Sanitizing Wipes Provide Clinical Efficacy as well as Convenience for Healthcare Workers and Patients ORANGEBURG, N.Y., Sept.
- A serpent whose bite was fabled to produce intense thirst.